Mobile diagnostic value Opportunity to position iFirst as a mobile, bedside coagulation solution that enables pre-arrival data to the hospital, supporting faster treatment decisions and potential upsell to hospital laboratories and ER departments.

Early adoption opening Target acute care facilities with trauma, surgical centers, and emergency departments that require advanced anticoagulation and coagulopathy monitoring, where current PT/INR tests are insufficient.

Cost and ease Leverage the product’s low-cost, user-friendly mobile platform to appeal to smaller hospitals, clinics, and ambulatory surgical centers seeking affordable, rapid diagnostics.

Platform expansion Position as a broader mobile health diagnostic platform with potential cross-sell into blood product planning and perioperative management, creating integration opportunities with hospital supply and blood banks.

Strategic partnerships Pursue collaborations with large medical device firms and health systems to accelerate commercialization, leveraging their distribution channels, procurement networks, and clinical validation to scale revenue.